공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

말라리아 : 파이프라인 리뷰

Malaria (Infectious Disease) - Drugs in Development, 2021

리서치사 Global Markets Direct
발행일 2021년 09월 상품 코드 192690
페이지 정보 영문 450 Pages
가격
US $ 2,500 ₩ 2,993,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,987,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,981,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


말라리아 : 파이프라인 리뷰 Malaria (Infectious Disease) - Drugs in Development, 2021
발행일 : 2021년 09월 페이지 정보 : 영문 450 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

말라리아란 학질모기를 매개로 사람에게 옮겨진 기생충이 일으키는 생사와 관련된 혈액성 질환입니다. 중증 환자가 될 위험이 높은 것은 유아, 비감염 지역으로부터 온 여행자, 임신중인 여성과 체내에 있는 신생아 등입니다. 주요 증상으로 발열, 오한, 두통, 발한, 권태감, 비장 비대, 구역질·구토 등을 들 수 있습니다. 주요 치료법에는 항말라리아제와 건강한 생활 습관 등이 있습니다.

세계 각국에서의 말라리아(Malaria) 치료용 파이프라인 제품 개발 상황에 대해 분석했으며, 제품 개발·출시 최신 동향, 각 임상 단계별 제품 목록, 주요 기업 개요, 주요 치료제 개요, 최신 업계 동향 등의 정보를 전해드립니다.

목차

서론

  • 분석 범위

말라리아 개요

치료제 개발

  • 말라리아용 파이프라인 제품 : 개요
  • 각 기업에서 개발중인 말라리아 치료제
  • 대학/연구기관에서 연구중인 말라리아 치료제
  • 말라리아 치료제 : 개발중인 제품 목록(기업별)
  • 말라리아 치료제 : 연구중인 제품 목록(대학/연구기관별)

말라리아 : 치료제 평가

  • 표적별
  • 작용기전별
  • 투여 방법별
  • 분자 종류별

말라리아 치료제 개발 참여 기업

약제 개요

말라리아 치료제 : 개발 휴지 상태 제품

말라리아 치료제 : 개발이 중지된 제품

말라리아 관련 제품 개발 마일스톤

  • 주목해야 할 최신 동향 및 프레스 릴리스

부록

도표

LSH 17.05.30

List of Tables

List of Tables

  • Number of Products under Development for Malaria, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Companies, 2021 (Contd..1)
  • Number of Products under Development by Companies, 2021 (Contd..2)
  • Number of Products under Development by Companies, 2021 (Contd..3)
  • Number of Products under Development by Companies, 2021 (Contd..4)
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products under Development by Universities/Institutes, 2021 (Contd..1)
  • Number of Products under Development by Universities/Institutes, 2021 (Contd..2)
  • Number of Products under Development by Universities/Institutes, 2021 (Contd..3)
  • Products under Development by Companies, 2021
  • Products under Development by Companies, 2021 (Contd..1)
  • Products under Development by Companies, 2021 (Contd..2)
  • Products under Development by Companies, 2021 (Contd..3)
  • Products under Development by Companies, 2021 (Contd..4)
  • Products under Development by Companies, 2021 (Contd..5)
  • Products under Development by Companies, 2021 (Contd..6)
  • Products under Development by Companies, 2021 (Contd..7)
  • Products under Development by Companies, 2021 (Contd..8)
  • Products under Development by Universities/Institutes, 2021
  • Products under Development by Universities/Institutes, 2021 (Contd..1)
  • Products under Development by Universities/Institutes, 2021 (Contd..2)
  • Products under Development by Universities/Institutes, 2021 (Contd..3)
  • Products under Development by Universities/Institutes, 2021 (Contd..4)
  • Products under Development by Universities/Institutes, 2021 (Contd..5)
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Target, 2021 (Contd..1)
  • Number of Products by Stage and Target, 2021 (Contd..2)
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Malaria - Pipeline by 4SC AG, 2021
  • Malaria - Pipeline by 60 Degrees Pharmaceuticals LLC, 2021
  • Malaria - Pipeline by AbbVie Inc, 2021
  • Malaria - Pipeline by AchilleS Vaccines Srl, 2021
  • Malaria - Pipeline by Akshaya Bio Inc, 2021
  • Malaria - Pipeline by Alfasigma SpA, 2021
  • Malaria - Pipeline by AliquantumRx Inc, 2021
  • Malaria - Pipeline by Allergy Therapeutics Plc, 2021
  • Malaria - Pipeline by Altimmune Inc, 2021
  • Malaria - Pipeline by Amivas LLC, 2021
  • Malaria - Pipeline by Artemis Therapeutics Inc, 2021
  • Malaria - Pipeline by Artificial Cell Technologies Inc, 2021
  • Malaria - Pipeline by AUM LifeTech Inc, 2021
  • Malaria - Pipeline by Avalia Immunotherapies Ltd, 2021
  • Malaria - Pipeline by Bharat Biotech Ltd, 2021
  • Malaria - Pipeline by BioNTech SE, 2021
  • Malaria - Pipeline by Brain-Gen LLC, 2021
  • Malaria - Pipeline by Bristol-Myers Squibb Co, 2021
  • Malaria - Pipeline by Cadila Healthcare Ltd, 2021
  • Malaria - Pipeline by Carna Biosciences Inc, 2021
  • Malaria - Pipeline by Cascade Therapeutics Inc, 2021
  • Malaria - Pipeline by Cellics Therapeutics Inc, 2021
  • Malaria - Pipeline by Cesa Alliance SA, 2021
  • Malaria - Pipeline by Cilian AG, 2021
  • Malaria - Pipeline by Collaborations Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by Curevac NV, 2021
  • Malaria - Pipeline by Daiichi Sankyo Co Ltd, 2021
  • Malaria - Pipeline by DesignMedix Inc, 2021
  • Malaria - Pipeline by DMG Deutsche Malaria GmbH, 2021
  • Malaria - Pipeline by Eisai Co Ltd, 2021
  • Malaria - Pipeline by ElSohly Laboratories Inc, 2021
  • Malaria - Pipeline by EpicentRx Inc, 2021
  • Malaria - Pipeline by EpiVax Inc, 2021
  • Malaria - Pipeline by eTheRNA Immunotherapies NV, 2021
  • Malaria - Pipeline by Evotec SE, 2021
  • Malaria - Pipeline by Expres2ion Biotechnologies ApS, 2021
  • Malaria - Pipeline by Exscientia Ltd, 2021
  • Malaria - Pipeline by GlaxoSmithKline Plc, 2021
  • Malaria - Pipeline by Hawaii Biotech Inc, 2021
  • Malaria - Pipeline by Ichor Medical Systems Inc, 2021
  • Malaria - Pipeline by Immtech Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by Immune Modulation Inc, 2021
  • Malaria - Pipeline by Imutex Ltd, 2021
  • Malaria - Pipeline by IMV Inc, 2021
  • Malaria - Pipeline by Indoco Remedies Ltd, 2021
  • Malaria - Pipeline by Innovex Therapeutics SL, 2021
  • Malaria - Pipeline by IPCA Laboratories Ltd, 2021
  • Malaria - Pipeline by Jacobus Pharmaceutical Co Inc, 2021
  • Malaria - Pipeline by Johnson & Johnson, 2021
  • Malaria - Pipeline by Kainomyx Inc, 2021
  • Malaria - Pipeline by Kymab Ltd, 2021
  • Malaria - Pipeline by LondonPharma Ltd, 2021
  • Malaria - Pipeline by Luckwel Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by Lumen Bioscience Inc, 2021
  • Malaria - Pipeline by Lyndra Therapeutics Inc., 2021
  • Malaria - Pipeline by MedinCell SA, 2021
  • Malaria - Pipeline by MediSynergics LLC, 2021
  • Malaria - Pipeline by MegaNano BioTech Inc, 2021
  • Malaria - Pipeline by Merck & Co Inc, 2021
  • Malaria - Pipeline by Merck KGaA, 2021
  • Malaria - Pipeline by Microbiotix Inc, 2021
  • Malaria - Pipeline by Mitsubishi Tanabe Pharma Corp, 2021
  • Malaria - Pipeline by Mycosynthetix Inc, 2021
  • Malaria - Pipeline by Mymetics Corp, 2021
  • Malaria - Pipeline by Nobelpharma Co Ltd, 2021
  • Malaria - Pipeline by Novartis AG, 2021
  • Malaria - Pipeline by Ocean Biomedical Inc, 2021
  • Malaria - Pipeline by Osivax SAS, 2021
  • Malaria - Pipeline by Otsuka Holdings Co Ltd, 2021
  • Malaria - Pipeline by Pacific Meniuoke Biopharmaceutical Company, 2021
  • Malaria - Pipeline by Pfizer Inc, 2021
  • Malaria - Pipeline by PGTx Ltd, 2021
  • Malaria - Pipeline by Protein Potential LLC, 2021
  • Malaria - Pipeline by Radix Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by Replikins Ltd, 2021
  • Malaria - Pipeline by Rodos BioTarget GmbH, 2021
  • Malaria - Pipeline by Sanaria Inc, 2021
  • Malaria - Pipeline by Sanofi, 2021
  • Malaria - Pipeline by Serum Institute of India Pvt Ltd, 2021
  • Malaria - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co Ltd, 2021
  • Malaria - Pipeline by Shin Poong Pharm Co Ltd, 2021
  • Malaria - Pipeline by Shionogi & Co Ltd, 2021
  • Malaria - Pipeline by Sumaya Biotech GmbH & Co KG, 2021
  • Malaria - Pipeline by Sumitomo Dainippon Pharma Co Ltd, 2021
  • Malaria - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
  • Malaria - Pipeline by Tandem Nano Ltd, 2021
  • Malaria - Pipeline by Tarsus Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by Titan Pharmaceuticals Inc, 2021
  • Malaria - Pipeline by UCB SA, 2021
  • Malaria - Pipeline by Uvax Bio LLC, 2021
  • Malaria - Pipeline by Vac4All SAS, 2021
  • Malaria - Pipeline by VicuTec Biologicals GmbH, 2021
  • Malaria - Pipeline by VLP Biotech Inc, 2021
  • Malaria - Pipeline by VLP Therapeutics LLC, 2021
  • Malaria - Dormant Projects, 2021
  • Malaria - Dormant Projects, 2021 (Contd..1)
  • Malaria - Dormant Projects, 2021 (Contd..2)
  • Malaria - Dormant Projects, 2021 (Contd..3)
  • Malaria - Dormant Projects, 2021 (Contd..4)
  • Malaria - Dormant Projects, 2021 (Contd..5)
  • Malaria - Dormant Projects, 2021 (Contd..6)
  • Malaria - Dormant Projects, 2021 (Contd..7)
  • Malaria - Dormant Projects, 2021 (Contd..8)
  • Malaria - Dormant Projects, 2021 (Contd..9)
  • Malaria - Dormant Projects, 2021 (Contd..10)
  • Malaria - Dormant Projects, 2021 (Contd..11)
  • Malaria - Discontinued Products, 2021
  • Malaria - Discontinued Products, 2021 (Contd..1)

List of Figures

List of Figures

  • Number of Products under Development for Malaria, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an overview of the Malaria (Infectious Disease) pipeline landscape.Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Malaria - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 1, 4, 15, 16, 58, 43 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 10, 20, 40 and 35 molecules, respectively.

Malaria (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Malaria (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Malaria (Infectious Disease)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Malaria (Infectious Disease).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Malaria (Infectious Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Malaria - Overview
  • Malaria - Therapeutics Development
  • Malaria - Therapeutics Assessment
  • Malaria - Companies Involved in Therapeutics Development
  • Malaria - Drug Profiles
  • Malaria - Dormant Projects
  • Malaria - Discontinued Products
  • Malaria - Product Development Milestones
  • Appendix
Back to Top
전화 문의
F A Q